A BRCA1 nonsense mutation causes exon skipping.

The authors would like to thank the family members. We also thank C. Bonnardel, L. Boutrand, T. Conway, J. Lynch, S. Slominski, and P. Watson, for their expert assistance. This work was supported by program grants from le Comite Departemental de l'Ain de La Ligue contre le Cancer, the Council for Tobacco Research (grant 127DR@), the U.S. Department of the Army (grant DAMD17-94-J-4340), and the Nebraska State Cancer and Smoking-Related Diseases Grant Program. N.P. is a fellow of the Ligue contre le Cancer de Haute-Savoie.

[1]  H. Dietz,et al.  Maintenance of an open reading frame as an additional level of scrutiny during splice site selection , 1994, Nature Genetics.

[2]  C. Mathew,et al.  A nonsense mutation and exon skipping in the Fanconi anaemia group C gene. , 1993, Human molecular genetics.

[3]  K. Weinberg,et al.  Three new adenosine deaminase mutations that define a splicing enhancer and cause severe and partial phenotypes: implications for evolution of a CpG hotspot and expression of a transduced ADA cDNA. , 1995, Human molecular genetics.

[4]  F. Couch,et al.  Mutations and Polymorphisms in the familial early‐onset breast cancer (BRCA1) gene , 1996, Human mutation.

[5]  A. Harris,et al.  The stop mutation R553X in the CFTR gene results in exon skipping. , 1994, Genomics.

[6]  M. Skolnick,et al.  Identification of a 14 kb deletion involving the promoter region of BRCA1 in a breast cancer family. , 1997, Human molecular genetics.

[7]  Chun-Fang Xu,et al.  Mutations and alternative splicing of the BRCA1 gene in UK breast/ovarian cancer families , 1997, Genes, chromosomes & cancer.

[8]  J. Mornon,et al.  From BRCA1 to RAP1: a widespread BRCT module closely associated with DNA repair , 1997, FEBS letters.

[9]  D. Clayton,et al.  Germline mutations of the BRCA1 gene in breast and ovarian cancer families provide evidence for a genotype–phenotype correlation , 1995, Nature Genetics.

[10]  L. Maquat.  Defects in RNA splicing and the consequence of shortened translational reading frames. , 1996, American journal of human genetics.

[11]  T. Cooper,et al.  The regulation of splice-site selection, and its role in human disease. , 1997, American journal of human genetics.

[12]  J. Pié,et al.  A nonsense mutation in the 3-hydroxy-3-methylglutaryl-CoA lyase gene produces exon skipping in two patients of different origin with 3-hydroxy-3-methylglutaryl-CoA lyase deficiency. , 1997, The Biochemical journal.

[13]  G. Lenoir,et al.  A 1-kb Alu-mediated germ-line deletion removing BRCA1 exon 17. , 1997, Cancer research.

[14]  Steven E. Bayer,et al.  A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. , 1994, Science.

[15]  C. Bonaïti‐pellié,et al.  Effects of misspecifying genetic parameters in lod score analysis. , 1986, Biometrics.

[16]  David Valle,et al.  The skipping of constitutive exons in vivo induced by nonsense mutations , 1993, Science.

[17]  F. Giannelli,et al.  Analysis of factor VIII mRNA reveals defects in everyone of 28 haemophilia A patients. , 1993, Human molecular genetics.

[18]  M. Skolnick,et al.  A collaborative survey of 80 mutations in the BRCA1 breast and ovarian cancer susceptibility gene. Implications for presymptomatic testing and screening. , 1995, JAMA.